{"id":"W4402494964","doi":"10.1038/s41523-024-00679-7","title":"Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Breast Cancer Foundation; Breast Cancer Research Foundation","keywords":"Pembrolizumab; Oncology; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00567236,0.001043997,0.002001608,0.0002605312,0.0003209542,0.0007946623,0.0005965465,0.0008815889,0.003347237],"category_scores_gemma":[0.002910625,0.0004129788,0.002450276,0.0005302888,0.0006631884,0.0007967941,0.0004276154,0.002267619,0.0005150884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008332247,"about_ca_system_score_gemma":0.001464439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008764242,"about_ca_topic_score_gemma":0.002416152,"domain_scores_codex":[0.9982382,0.001086591,0.0001618607,0.0002158118,0.0001542168,0.0001433275],"domain_scores_gemma":[0.9983789,0.0004315849,0.0005185879,0.0001635209,0.0001336533,0.0003738522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9364061,0.007515162,0.00816372,0.001449728,0.005607973,0.00008815599,0.0001410675,0.0007597858,0.004493731,0.0002467181,0.003627782,0.03150002],"study_design_scores_gemma":[0.8153471,0.1204142,0.0483002,0.0001970677,0.008402058,0.0001858805,0.0001073644,0.0008373369,0.001121568,0.0004388953,0.004597344,0.00005096358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752743,0.008900498,0.001272071,0.00136314,0.0003810095,0.004515249,0.004825549,0.0001061873,0.003362044],"genre_scores_gemma":[0.9848256,0.003045971,0.00121555,0.0020149,0.0002445756,0.002982952,0.004503973,0.0000224036,0.001144125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00567236,"threshold_uncertainty_score":0.02999872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008130626764051447,"score_gpt":0.2726968127594168,"score_spread":0.2645661859953653,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}